Affiliation:
1. Mental Health Center, West China Hospital of Sichuan University
2. West China Fourth Hospital of Sichuan University
3. The Fourth People’s Hospital of Chengdu
Abstract
Abstract
Background.
In clinical, many patients with severe mental illness (SMI) have a relapse and deterioration in their illness during COVID-19, with an experienced medication interruption. This study aimed to investigate factors affecting medicine interruption in patients with SMI during the COVID-19 pandemic.
Methods.
Between 3 September and 7 October 2020, 2,077 patients with SMI participated in an online survey regarding their medication interruption during the COVID-19 outbreak. The questionnaire comprised six parts: basic demographic information, COVID-19 exposure, state of disease, medication compliance pre-COVID-19, medication interruption during COVID-19, and the specific impact and needs.
Results.
2,017 valid questionnaires were collected. Nearly 50% of patients with SMI have been affected to varying degrees in their lives and treatment. Among them, 74 patients stopped taking medicines for more than 14 days without a prescription. Binary logistic regression analysis showed that cohabitant exposure [OR = 26.629; 95% CI (3.293-215.323), p = 0.002], medication partial compliance and non-compliance pre-COVID-19 [OR = 11.109; 95% CI (6.093–20.251), p < 0.001; OR = 20.115; 95% CI (10.490-38.571), p < 0.001], and disease status [OR = 0.326; 95% CI (0.188–0.564), p < 0.001] were related to medication interruption. More than 50% of patients wanted help in taking medications, follow-up, and receiving more financial support and protective materials.
Conclusions.
Patients with a history of partial or non-medication compliance pre-COVID-19 and unstable disease state are more easily affect by epidemics and need extra attention should similar large-scale epidemics occur in future.
Publisher
Research Square Platform LLC